Akebia Therapeutics, Inc. (59) | Stock Agreements (2)
- Form of Officer Restricted Stock Unit Award Agreement (Filed With SEC on August 4, 2022)
- Keryx Biopharmaceuticals, Inc. Director Non-Statutory Stock Option Award Terms and Conditions under the Third Amended and Restated Directors Equity Compensation Plan (Filed With SEC on March 26, 2019)
